BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 9692696)

  • 1. Sex hormone status and bone metabolism in men with Crohn's disease.
    Robinson RJ; Iqbal SJ; Al-Azzawi F; Abrams K; Mayberry JF
    Aliment Pharmacol Ther; 1998 Jan; 12(1):21-5. PubMed ID: 9692696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bones and Crohn's: estradiol deficiency in men with Crohn's disease is not associated with reduced bone mineral density.
    Klaus J; Reinshagen M; Adler G; Boehm B; von Tirpitz C
    BMC Gastroenterol; 2008 Oct; 8():48. PubMed ID: 18947388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low serum and bone vitamin K status in patients with longstanding Crohn's disease: another pathogenetic factor of osteoporosis in Crohn's disease?
    Schoon EJ; Müller MC; Vermeer C; Schurgers LJ; Brummer RJ; Stockbrügger RW
    Gut; 2001 Apr; 48(4):473-7. PubMed ID: 11247890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex steroids, biochemical markers, bone mineral density and histomorphometry in male osteoporosis patients.
    Fassbender WJ; Balli M; Görtz B; Hinrichs B; Kaiser HE; Tracke HS
    In Vivo; 2000; 14(5):611-8. PubMed ID: 11125545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoporosis and determinants of bone density in patients with Crohn's disease.
    Robinson RJ; al-Azzawi F; Iqbal SJ; Kryswcki T; Almond L; Abrams K; Mayberry JF
    Dig Dis Sci; 1998 Nov; 43(11):2500-6. PubMed ID: 9824142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoporosis in men: a potential role for the sex hormone binding globulin.
    Legrand E; Hedde C; Gallois Y; Degasne I; Boux de Casson F; Mathieu E; Baslé MF; Chappard D; Audran M
    Bone; 2001 Jul; 29(1):90-5. PubMed ID: 11472897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The frequency of low bone mineral density and its associated risk factors in patients with inflammatory bowel diseases.
    Ezzat Y; Hamdy K
    Int J Rheum Dis; 2010 Aug; 13(3):259-65. PubMed ID: 20704624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of bone density in healthy older men with low testosterone levels.
    Kenny AM; Prestwood KM; Marcello KM; Raisz LG
    J Gerontol A Biol Sci Med Sci; 2000 Sep; 55(9):M492-7. PubMed ID: 10995046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn's disease and ulcerative colitis.
    Ardizzone S; Bollani S; Bettica P; Bevilacqua M; Molteni P; Bianchi Porro G
    J Intern Med; 2000 Jan; 247(1):63-70. PubMed ID: 10672132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic bone assessment in patients with inflammatory bowel disease.
    Abitbol V; Roux C; Chaussade S; Guillemant S; Kolta S; Dougados M; Couturier D; Amor B
    Gastroenterology; 1995 Feb; 108(2):417-22. PubMed ID: 7835582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis.
    Bernstein CN; Seeger LL; Sayre JW; Anton PA; Artinian L; Shanahan F
    J Bone Miner Res; 1995 Feb; 10(2):250-6. PubMed ID: 7754804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low body size and elevated sex-hormone binding globulin distinguish men with idiopathic vertebral fracture.
    Evans SF; Davie MW
    Calcif Tissue Int; 2002 Jan; 70(1):9-15. PubMed ID: 11907702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The frequency of vitamin D deficiency in adults with Crohn's disease.
    Siffledeen JS; Siminoski K; Steinhart H; Greenberg G; Fedorak RN
    Can J Gastroenterol; 2003 Aug; 17(8):473-8. PubMed ID: 12945007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of osteopenia in men with prolactinoma.
    Naliato EC; Farias ML; Braucks GR; Costa FS; Zylberberg D; Violante AH
    J Endocrinol Invest; 2005 Jan; 28(1):12-7. PubMed ID: 15816365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen supplementation in eugonadal men with osteoporosis: effects of six months' treatment on markers of bone formation and resorption.
    Anderson FH; Francis RM; Peaston RT; Wastell HJ
    J Bone Miner Res; 1997 Mar; 12(3):472-8. PubMed ID: 9076591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutifactorial analysis of risk factors for reduced bone mineral density in patients with Crohn's disease.
    Bartram SA; Peaston RT; Rawlings DJ; Walshaw D; Francis RM; Thompson NP
    World J Gastroenterol; 2006 Sep; 12(35):5680-6. PubMed ID: 17007022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased bone resorption in patients with Crohn's disease.
    Robinson RJ; Iqbal SJ; Abrams K; Al-Azzawi F; Mayberry JF
    Aliment Pharmacol Ther; 1998 Aug; 12(8):699-705. PubMed ID: 9726381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of bone mineral density in stable kidney transplant recipients.
    Gupta AK; Huang M; Prasad GV
    J Nephrol; 2012; 25(3):373-83. PubMed ID: 21928224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Femoral neck osteopenia in patients with inflammatory bowel disease.
    Pollak RD; Karmeli F; Eliakim R; Ackerman Z; Tabb K; Rachmilewitz D
    Am J Gastroenterol; 1998 Sep; 93(9):1483-90. PubMed ID: 9732930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of dehydroepiandrosterone sulfate and testosterone deficiency with bone turnover in men with inflammatory bowel disease.
    Szathmári M; Vásárhelyi B; Treszl A; Tulassay T; Tulassay Z
    Int J Colorectal Dis; 2002 Mar; 17(2):63-6. PubMed ID: 12014422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.